Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Human coagulation factor IX in hemophilia B
CTR20170472Phase 3Completed
- Sponsor
- Shandong Taibang Biological Products
- Start
- May 2017
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of coagulation factor ix in hemophilia B (HB), sponsored by Shandong Taibang Biological Products. Started May 2017; status: completed.
02
Drugs
coagulation factor ix
03
Conditions
hemophilia B (HB)
Beyond the preview
Go deeper on CTR20170472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170472.